Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2002

View Archived Issues

Verapamil is effective in the treatment of Peyronie's disease

ABI-007, a new cremophor-free nanoparticle formulation of paclitaxel

Kansas State University researchers identify nucleoside transport inhibitor TT-24

IL-10 gene therapy prevents recurrence of autoimmune diabetes after islet transplantation

CD45RB MAb prolongs allograft survival in mice

Bimosiamose prolongs rat kidney allograft survival by reducing intragraft cytokine production

Inhibition of COX-2 with NS-398 prolongs allogeneic cardiac graft survival

Takeda presents SAR studies for TAK-013 and TAK-810

UCB-35440 discussed at recent ACS meeting

Cyclic beta-amino acids with VLA-4 antagonist activity presented at ACS

Milnacipran to be studied in depressed mood associated with chronic pain conditions

Pfizer submits IND for bone growth product

Sankyo files supplemental NDA for Benicar HCT

Lantus launch in U.K.

P-54 may reduce steroid dependency in patients with mild inflammatory bowel disease

Xigris approved in E.U.

Orion files NDA for triple combination therapy for Parkinson's disease

A-317920 shows potential for Alzheimer's disease and ADHD

Bayer claims compounds with antitumor activity

Orexin receptor antagonists described by Actelion

Antifungal compounds that inhibit CIV1 activity

Telomerase-inhibiting compounds described by Geron and Kyowa Hakko

New mGLUR1 antagonists claimed by Roche for neurological disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...